ProQR to Host Virtual Investor Event Highlighting Pipeline on April 8, 2026

ProQR Therapeutics will host a virtual investor and analyst event on April 8, 2026, to showcase its RNA editing pipeline, announce new programs with clinical data readouts, and unveil the primary indication for AX-0810. The event will highlight the company's Axiomer RNA editing technology platform and its potential to yield a new class of medicines for various diseases. The virtual format will include webcast presentations and Q&A with covering analysts and management. Registration is available at lifescievents.com/event/g09gufqylu/.